Contact

Representative before the EPO

Employment test 201 - 500 employees
Company dna zacco
operating since 2001
Headquarter in Copenhagen and 15 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna zacco norway as
no operation time available
1 office
active in Legal Services

We have observed 2 EP applications Rita Lillegraven has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after February 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11837647

METHODS OF TREATMENT USING LIPID COMPOUNDS

IPC classification:
A61K 31/19, A61P 3/04, A61P 3/06, A61P 3/10, A61P 9/10, C07C 57/03
Agent:
Rita Lillegraven, Zacco Norway AS
Status:
PATENT GRANTED
EP11807110

PARENTERAL FORMULATIONS OF ELACYTARABINE DERIVATIVES

IPC classification:
A61K 9/00, A61K 9/107, A61K 9/127, A61K 31/7056, A61K 47/48, C07H 19/06
Agent:
Rita Lillegraven, Zacco Norway AS
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature